Exploring different composite definitions of responders and non-responders to biologic treatment for severe asthma (FULL BEAM)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/104133
• EU PAS number:
  EUPAS104132
• Study ID:
  104133
• Official title and acronym:
  Exploring different composite definitions of responders and non-responders to biologic treatment for severe asthma (FULL BEAM)
• DARWIN EU® study:
  No
• Study countries:
  Argentina

  Australia

  Bulgaria

  Canada

  Colombia

  Denmark

  Greece

  India

  Ireland

  Italy

  Japan

  Korea, Republic of

  Kuwait

  Mexico

  Poland

  Portugal

  Saudi Arabia

  Taiwan

  United Arab Emirates

  United Kingdom

  United States
• Study status:
  Planned

Research institutions and networks

Institutions

Observational & Pragmatic Research Institute Pte (OPRI)

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 01/03/2022

Study start date

Planned: 02/05/2022

Date of interim report, if expected

Planned: 30/12/2022

Date of final study report

Planned: 30/04/2023

Sources of funding

Other

Pharmaceutical company and other private sector 

More details on funding

AstraZeneca, OPRI Pte Ltd

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable